GluBio Therapeutics

Glu Bio Therapeutics

Biotechnology, 345 Park Ave, New York, 10154, United States, 11-50 Employees

glubiotx.com

  • LinkedIn

phone no Phone Number: +12*********

Who is GLUBIO THERAPEUTICS

GluBio Therapeutics is a pioneering TPD company dedicated to developing targeted protein degraders for human diseases with unmet medical needs. Founded by seasoned drug developers with de...

Read More

map
  • 345 Park Ave, New York, New York, 10154, United States Headquarters: 345 Park Ave, New York, New York, 10154, United States
  • 2021 Date Founded: 2021
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Billion and Over
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from GLUBIO THERAPEUTICS

GluBio Therapeutics Org Chart and Mapping

Employees

Wei Li

Senior Medical Writer

Jean Lu

Senior Principal Scientist

Yan Xie

Principal Scientist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding GluBio Therapeutics

Answer: GluBio Therapeutics's headquarters are located at 345 Park Ave, New York, 10154, United States

Answer: GluBio Therapeutics's phone number is +12*********

Answer: GluBio Therapeutics's official website is https://glubiotx.com

Answer: GluBio Therapeutics's revenue is $1 Billion and Over

Answer: GluBio Therapeutics's SIC: 2836

Answer: GluBio Therapeutics's NAICS: 541714

Answer: GluBio Therapeutics has 11-50 employees

Answer: GluBio Therapeutics is in Biotechnology

Answer: GluBio Therapeutics contact info: Phone number: +12********* Website: https://glubiotx.com

Answer: GluBio Therapeutics is a pioneering TPD company dedicated to developing targeted protein degraders for human diseases with unmet medical needs. Founded by seasoned drug developers with deep knowledge and expertise in TPD drug discovery, the company has established a proprietary TPD discovery platform and robust screening capability. GluBio is advancing a diverse pipeline of highly selective small-molecule degraders across multiple therapeutic areas including oncology and immunology. The company has research operations in both San Diego, CA, USA and Shanghai, China.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access